This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: William L Nicholson: Innovator in Pathogenic Research
Introduction
William L Nicholson is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of pathogenic research, particularly in understanding tick-borne viruses. His work has implications for public health and disease prevention.
Latest Patents
William L Nicholson holds a patent for "Pathogenic phlebovirus isolates and compositions and methods of use." This patent describes the clinical and laboratory characteristics of two patients bitten by ticks and infected with a unique member of the genus Bunyaviridae, proposed to be named Heartland virus (HRTLV). The patent provides nucleotide and amino acid sequences of the isolates, primers and probes that specifically hybridize with the isolates, and antibodies specific for the proteins. Additionally, it includes detection assays using the nucleic acid molecules, proteins, probes, primers, and antibodies. The patent also discusses recombinant methods and their use for eliciting an immune response in a subject.
Career Highlights
William L Nicholson is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this capacity has allowed him to contribute to important research that addresses public health challenges.
Collaborations
Some of his notable coworkers include Laura K McMullan and Stuart T Nichol. Their collaborative efforts have further advanced the understanding of tick-borne diseases and their implications.
Conclusion
William L Nicholson's innovative work in pathogenic research highlights the importance of understanding emerging viruses and their impact on health. His contributions through patents and collaborations continue to shape the field and enhance public health initiatives.
